Engineered immune cells take on Hard-to-Treat colon cancer
Disease control
Recruiting now
This early-stage trial is testing a new treatment called CNA3103 for people with metastatic colorectal cancer that has spread and not responded well to standard treatments. CNA3103 is made from a patient's own immune cells, which are modified in a lab to better recognize and atta…
Phase: PHASE1, PHASE2 • Sponsor: Carina Biotech Limited • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC